These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22048253)

  • 1. Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions.
    Chatagnon A; Perriaud L; Nazaret N; Croze S; Benhattar J; Lachuer J; Dante R
    Epigenetics; 2011 Nov; 6(11):1295-307. PubMed ID: 22048253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2.
    Stefanska B; Suderman M; Machnes Z; Bhattacharyya B; Hallett M; Szyf M
    Carcinogenesis; 2013 Dec; 34(12):2738-49. PubMed ID: 23955541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
    Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
    Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
    Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
    Gu P; Le Menuet D; Chung AC; Cooney AJ
    Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the DNA methylation system component MBD2 by protein arginine methylation.
    Tan CP; Nakielny S
    Mol Cell Biol; 2006 Oct; 26(19):7224-35. PubMed ID: 16980624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
    Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
    Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.
    Auriol E; Billard LM; Magdinier F; Dante R
    Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
    Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
    J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "Methyl-CpG Binding Domain protein 2" plays a repressive role in relation to the promoter CpG content in the normal human cell line MRC5.
    Perriaud L; Lachuer J; Dante R
    Curr Pharm Des; 2014; 20(11):1598-603. PubMed ID: 23888954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide binding of MBD2 reveals strong preference for highly methylated loci.
    Menafra R; Brinkman AB; Matarese F; Franci G; Bartels SJ; Nguyen L; Shimbo T; Wade PA; Hubner NC; Stunnenberg HG
    PLoS One; 2014; 9(6):e99603. PubMed ID: 24927503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X; Nelson WG
    Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias.
    Nair SS; Coolen MW; Stirzaker C; Song JZ; Statham AL; Strbenac D; Robinson MD; Clark SJ
    Epigenetics; 2011 Jan; 6(1):34-44. PubMed ID: 20818161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level.
    Pan H; Bilinovich SM; Kaur P; Riehn R; Wang H; Williams DC
    Nucleic Acids Res; 2017 Sep; 45(15):9164-9177. PubMed ID: 28637186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression.
    Ghoshal K; Majumder S; Datta J; Motiwala T; Bai S; Sharma SM; Frankel W; Jacob ST
    J Biol Chem; 2004 Feb; 279(8):6783-93. PubMed ID: 14610093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells.
    Bakker J; Lin X; Nelson WG
    J Biol Chem; 2002 Jun; 277(25):22573-80. PubMed ID: 11960994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells.
    Devailly G; Grandin M; Perriaud L; Mathot P; Delcros JG; Bidet Y; Morel AP; Bignon JY; Puisieux A; Mehlen P; Dante R
    Nucleic Acids Res; 2015 Jul; 43(12):5838-54. PubMed ID: 26007656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl CpG-binding proteins and transcriptional repression.
    Wade PA
    Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
    Jiang CL; Jin SG; Pfeifer GP
    J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.